nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—HTR2A—chronic obstructive pulmonary disease	0.644	1	CbGaD
Apomorphine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00938	0.415	CbGeAlD
Apomorphine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00341	0.151	CbGeAlD
Apomorphine—Rhinorrhoea—Montelukast—chronic obstructive pulmonary disease	0.0031	0.0168	CcSEcCtD
Apomorphine—Pallor—Salbutamol—chronic obstructive pulmonary disease	0.00292	0.0158	CcSEcCtD
Apomorphine—Contusion—Montelukast—chronic obstructive pulmonary disease	0.00288	0.0156	CcSEcCtD
Apomorphine—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.00285	0.0154	CcSEcCtD
Apomorphine—Urinary tract infection—Roflumilast—chronic obstructive pulmonary disease	0.00275	0.0149	CcSEcCtD
Apomorphine—Pain in extremity—Tiotropium—chronic obstructive pulmonary disease	0.00231	0.0125	CcSEcCtD
Apomorphine—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00223	0.012	CcSEcCtD
Apomorphine—Dehydration—Tiotropium—chronic obstructive pulmonary disease	0.00215	0.0116	CcSEcCtD
Apomorphine—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00214	0.0116	CcSEcCtD
Apomorphine—Cardiac failure congestive—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.0111	CcSEcCtD
Apomorphine—Cardiac failure congestive—Formoterol—chronic obstructive pulmonary disease	0.00206	0.0111	CcSEcCtD
Apomorphine—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.00194	0.0105	CcSEcCtD
Apomorphine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00188	0.0101	CcSEcCtD
Apomorphine—Dehydration—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00936	CcSEcCtD
Apomorphine—Dehydration—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00936	CcSEcCtD
Apomorphine—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00173	0.00934	CcSEcCtD
Apomorphine—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00167	0.009	CcSEcCtD
Apomorphine—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00167	0.009	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00164	0.00888	CcSEcCtD
Apomorphine—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00882	CcSEcCtD
Apomorphine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00163	0.00882	CcSEcCtD
Apomorphine—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.0085	CcSEcCtD
Apomorphine—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00157	0.00849	CcSEcCtD
Apomorphine—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.00157	0.00847	CcSEcCtD
Apomorphine—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.00157	0.00847	CcSEcCtD
Apomorphine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00156	0.0084	CcSEcCtD
Apomorphine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00154	0.00834	CcSEcCtD
Apomorphine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00149	0.00803	CcSEcCtD
Apomorphine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.008	CcSEcCtD
Apomorphine—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.008	CcSEcCtD
Apomorphine—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00764	CcSEcCtD
Apomorphine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00141	0.0076	CcSEcCtD
Apomorphine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00756	CcSEcCtD
Apomorphine—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00754	CcSEcCtD
Apomorphine—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00754	CcSEcCtD
Apomorphine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00732	CcSEcCtD
Apomorphine—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00726	CcSEcCtD
Apomorphine—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00712	CcSEcCtD
Apomorphine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.0013	0.00699	CcSEcCtD
Apomorphine—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00679	CcSEcCtD
Apomorphine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00679	CcSEcCtD
Apomorphine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00676	CcSEcCtD
Apomorphine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00674	CcSEcCtD
Apomorphine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00124	0.00667	CcSEcCtD
Apomorphine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.0066	CcSEcCtD
Apomorphine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.00645	CcSEcCtD
Apomorphine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00118	0.00639	CcSEcCtD
Apomorphine—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00639	CcSEcCtD
Apomorphine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00639	CcSEcCtD
Apomorphine—Contusion—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00625	CcSEcCtD
Apomorphine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00115	0.0062	CcSEcCtD
Apomorphine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00613	CcSEcCtD
Apomorphine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00113	0.00611	CcSEcCtD
Apomorphine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.0061	CcSEcCtD
Apomorphine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00113	0.0061	CcSEcCtD
Apomorphine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.0061	CcSEcCtD
Apomorphine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.00607	CcSEcCtD
Apomorphine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00112	0.00603	CcSEcCtD
Apomorphine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00601	CcSEcCtD
Apomorphine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00598	CcSEcCtD
Apomorphine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00588	CcSEcCtD
Apomorphine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00586	CcSEcCtD
Apomorphine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00586	CcSEcCtD
Apomorphine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00579	CcSEcCtD
Apomorphine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00576	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00558	CcSEcCtD
Apomorphine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00554	CcSEcCtD
Apomorphine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00554	CcSEcCtD
Apomorphine—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.00102	0.0449	CbGeAlD
Apomorphine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000971	0.00524	CcSEcCtD
Apomorphine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000956	0.00516	CcSEcCtD
Apomorphine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000956	0.00516	CcSEcCtD
Apomorphine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000956	0.00516	CcSEcCtD
Apomorphine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000956	0.00516	CcSEcCtD
Apomorphine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000952	0.00514	CcSEcCtD
Apomorphine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000952	0.00514	CcSEcCtD
Apomorphine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000951	0.00513	CcSEcCtD
Apomorphine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000936	0.00505	CcSEcCtD
Apomorphine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000933	0.00504	CcSEcCtD
Apomorphine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000932	0.00503	CcSEcCtD
Apomorphine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000916	0.00495	CcSEcCtD
Apomorphine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000916	0.00495	CcSEcCtD
Apomorphine—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000914	0.00493	CcSEcCtD
Apomorphine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000902	0.00487	CcSEcCtD
Apomorphine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000902	0.00487	CcSEcCtD
Apomorphine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000899	0.00486	CcSEcCtD
Apomorphine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000897	0.00485	CcSEcCtD
Apomorphine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000869	0.0384	CbGeAlD
Apomorphine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000865	0.00467	CcSEcCtD
Apomorphine—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000864	0.0382	CbGeAlD
Apomorphine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000856	0.00462	CcSEcCtD
Apomorphine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000856	0.00462	CcSEcCtD
Apomorphine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000852	0.0046	CcSEcCtD
Apomorphine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000851	0.0046	CcSEcCtD
Apomorphine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00085	0.00459	CcSEcCtD
Apomorphine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000836	0.00452	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000835	0.00451	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000835	0.00451	CcSEcCtD
Apomorphine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000829	0.00447	CcSEcCtD
Apomorphine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000829	0.00447	CcSEcCtD
Apomorphine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000824	0.00445	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000818	0.00441	CcSEcCtD
Apomorphine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000817	0.00441	CcSEcCtD
Apomorphine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000817	0.00441	CcSEcCtD
Apomorphine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000814	0.0044	CcSEcCtD
Apomorphine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000814	0.0044	CcSEcCtD
Apomorphine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000812	0.00438	CcSEcCtD
Apomorphine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000809	0.00437	CcSEcCtD
Apomorphine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000808	0.00436	CcSEcCtD
Apomorphine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000803	0.00434	CcSEcCtD
Apomorphine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000798	0.00431	CcSEcCtD
Apomorphine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000796	0.0043	CcSEcCtD
Apomorphine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00079	0.00426	CcSEcCtD
Apomorphine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00079	0.00426	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000788	0.00426	CcSEcCtD
Apomorphine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000783	0.00423	CcSEcCtD
Apomorphine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000783	0.00423	CcSEcCtD
Apomorphine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000782	0.00422	CcSEcCtD
Apomorphine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000774	0.00418	CcSEcCtD
Apomorphine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000771	0.00416	CcSEcCtD
Apomorphine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000769	0.00415	CcSEcCtD
Apomorphine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000765	0.00413	CcSEcCtD
Apomorphine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000755	0.00408	CcSEcCtD
Apomorphine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000755	0.00408	CcSEcCtD
Apomorphine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000754	0.00407	CcSEcCtD
Apomorphine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000751	0.00405	CcSEcCtD
Apomorphine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000746	0.00403	CcSEcCtD
Apomorphine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00074	0.00399	CcSEcCtD
Apomorphine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000722	0.0039	CcSEcCtD
Apomorphine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000716	0.00387	CcSEcCtD
Apomorphine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000715	0.00386	CcSEcCtD
Apomorphine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000713	0.00385	CcSEcCtD
Apomorphine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000711	0.00384	CcSEcCtD
Apomorphine—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000695	0.0307	CbGeAlD
Apomorphine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000674	0.00364	CcSEcCtD
Apomorphine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000657	0.00355	CcSEcCtD
Apomorphine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000657	0.00355	CcSEcCtD
Apomorphine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000648	0.0035	CcSEcCtD
Apomorphine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000648	0.0035	CcSEcCtD
Apomorphine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000644	0.00348	CcSEcCtD
Apomorphine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000635	0.00343	CcSEcCtD
Apomorphine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000627	0.00338	CcSEcCtD
Apomorphine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000627	0.00338	CcSEcCtD
Apomorphine—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000624	0.0276	CbGeAlD
Apomorphine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000621	0.00335	CcSEcCtD
Apomorphine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000618	0.00333	CcSEcCtD
Apomorphine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000614	0.00332	CcSEcCtD
Apomorphine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000612	0.0033	CcSEcCtD
Apomorphine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000606	0.00327	CcSEcCtD
Apomorphine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000606	0.00327	CcSEcCtD
Apomorphine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000593	0.0032	CcSEcCtD
Apomorphine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000593	0.0262	CbGeAlD
Apomorphine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000592	0.0032	CcSEcCtD
Apomorphine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000582	0.00315	CcSEcCtD
Apomorphine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000582	0.00315	CcSEcCtD
Apomorphine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000574	0.0031	CcSEcCtD
Apomorphine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000574	0.0031	CcSEcCtD
Apomorphine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000573	0.0253	CbGeAlD
Apomorphine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000572	0.00309	CcSEcCtD
Apomorphine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000571	0.00308	CcSEcCtD
Apomorphine—HTR2B—lung—chronic obstructive pulmonary disease	0.00057	0.0252	CbGeAlD
Apomorphine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000562	0.00304	CcSEcCtD
Apomorphine—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000555	0.0245	CbGeAlD
Apomorphine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.00297	CcSEcCtD
Apomorphine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000545	0.00294	CcSEcCtD
Apomorphine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000544	0.00294	CcSEcCtD
Apomorphine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000544	0.00294	CcSEcCtD
Apomorphine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000542	0.00293	CcSEcCtD
Apomorphine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000534	0.00289	CcSEcCtD
Apomorphine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000533	0.00288	CcSEcCtD
Apomorphine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000514	0.00277	CcSEcCtD
Apomorphine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000505	0.00273	CcSEcCtD
Apomorphine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000504	0.0223	CbGeAlD
Apomorphine—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000498	0.022	CbGeAlD
Apomorphine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000496	0.00268	CcSEcCtD
Apomorphine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000488	0.00264	CcSEcCtD
Apomorphine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00048	0.00259	CcSEcCtD
Apomorphine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000471	0.00254	CcSEcCtD
Apomorphine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000461	0.0204	CbGeAlD
Apomorphine—DRD2—lung—chronic obstructive pulmonary disease	0.000461	0.0204	CbGeAlD
Apomorphine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000449	0.00242	CcSEcCtD
Apomorphine—ADRA2C—lung—chronic obstructive pulmonary disease	0.000448	0.0198	CbGeAlD
Apomorphine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000445	0.0024	CcSEcCtD
Apomorphine—HTR2A—trachea—chronic obstructive pulmonary disease	0.000423	0.0187	CbGeAlD
Apomorphine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000409	0.00221	CcSEcCtD
Apomorphine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000396	0.00214	CcSEcCtD
Apomorphine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000388	0.0021	CcSEcCtD
Apomorphine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000376	0.00203	CcSEcCtD
Apomorphine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000375	0.00202	CcSEcCtD
Apomorphine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000361	0.00195	CcSEcCtD
Apomorphine—ADRA2A—lung—chronic obstructive pulmonary disease	0.000358	0.0158	CbGeAlD
Apomorphine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000355	0.00192	CcSEcCtD
Apomorphine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00188	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000328	0.00177	CcSEcCtD
Apomorphine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000328	0.00177	CcSEcCtD
Apomorphine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000326	0.00176	CcSEcCtD
Apomorphine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000311	0.00168	CcSEcCtD
Apomorphine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.00168	CcSEcCtD
Apomorphine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000308	0.00166	CcSEcCtD
Apomorphine—HTR2A—lung—chronic obstructive pulmonary disease	0.000304	0.0135	CbGeAlD
Apomorphine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000297	0.0016	CcSEcCtD
Apomorphine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.00159	CcSEcCtD
Apomorphine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000259	0.0014	CcSEcCtD
Apomorphine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00138	CcSEcCtD
Apomorphine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000247	0.00133	CcSEcCtD
Apomorphine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00129	CcSEcCtD
Apomorphine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00124	CcSEcCtD
Apomorphine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00122	CcSEcCtD
Apomorphine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00116	CcSEcCtD
Apomorphine—DRD3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.4e-05	0.000162	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.4e-05	0.000162	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.39e-05	0.000161	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.38e-05	0.000161	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.38e-05	0.000161	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.38e-05	0.000161	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.37e-05	0.00016	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.34e-05	0.000158	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.33e-05	0.000157	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.32e-05	0.000157	CbGpPWpGaD
Apomorphine—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	2.32e-05	0.000156	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.31e-05	0.000156	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.3e-05	0.000155	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.29e-05	0.000155	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.29e-05	0.000155	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.29e-05	0.000154	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.29e-05	0.000154	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.29e-05	0.000154	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.28e-05	0.000154	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.27e-05	0.000153	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.25e-05	0.000151	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.23e-05	0.00015	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.21e-05	0.000149	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.21e-05	0.000149	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.19e-05	0.000148	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.18e-05	0.000147	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.18e-05	0.000147	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.17e-05	0.000146	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	2.16e-05	0.000146	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.16e-05	0.000146	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.16e-05	0.000146	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.15e-05	0.000145	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.13e-05	0.000144	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.13e-05	0.000144	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.13e-05	0.000144	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.12e-05	0.000143	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.09e-05	0.000141	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.08e-05	0.00014	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.08e-05	0.00014	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.07e-05	0.00014	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.07e-05	0.000139	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.06e-05	0.000139	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.05e-05	0.000138	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.02e-05	0.000136	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.02e-05	0.000136	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.01e-05	0.000136	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.01e-05	0.000135	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.01e-05	0.000135	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.01e-05	0.000135	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.01e-05	0.000135	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2e-05	0.000135	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.99e-05	0.000134	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.99e-05	0.000134	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.99e-05	0.000134	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.98e-05	0.000133	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.97e-05	0.000133	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.97e-05	0.000133	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.96e-05	0.000132	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.96e-05	0.000132	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.93e-05	0.00013	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.93e-05	0.00013	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.91e-05	0.000129	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.9e-05	0.000128	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.88e-05	0.000127	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.88e-05	0.000127	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.87e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.86e-05	0.000125	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.85e-05	0.000125	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.84e-05	0.000124	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.83e-05	0.000123	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.82e-05	0.000123	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.81e-05	0.000122	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.81e-05	0.000122	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.8e-05	0.000121	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.8e-05	0.000121	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.8e-05	0.000121	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.8e-05	0.000121	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.79e-05	0.000121	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.78e-05	0.00012	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.77e-05	0.000119	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	1.76e-05	0.000118	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.76e-05	0.000118	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.76e-05	0.000118	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.75e-05	0.000118	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.75e-05	0.000118	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.72e-05	0.000116	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.7e-05	0.000114	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	1.68e-05	0.000114	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.67e-05	0.000113	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.67e-05	0.000113	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.66e-05	0.000112	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.64e-05	0.000111	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.63e-05	0.00011	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.63e-05	0.00011	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.62e-05	0.000109	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.62e-05	0.000109	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.61e-05	0.000109	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	1.61e-05	0.000109	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.61e-05	0.000108	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.6e-05	0.000108	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.6e-05	0.000108	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.6e-05	0.000108	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.58e-05	0.000107	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.58e-05	0.000106	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.57e-05	0.000106	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.57e-05	0.000106	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.54e-05	0.000104	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.53e-05	0.000103	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.52e-05	0.000103	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.52e-05	0.000102	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.52e-05	0.000102	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.51e-05	0.000102	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.5e-05	0.000101	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.48e-05	9.97e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.47e-05	9.88e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.46e-05	9.85e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.46e-05	9.83e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.46e-05	9.81e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.45e-05	9.78e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.45e-05	9.76e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.44e-05	9.73e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.44e-05	9.72e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.44e-05	9.68e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.42e-05	9.55e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.42e-05	9.55e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.41e-05	9.51e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.39e-05	9.39e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.39e-05	9.36e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.39e-05	9.34e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.38e-05	9.29e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	1.37e-05	9.22e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.37e-05	9.21e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.35e-05	9.08e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.35e-05	9.08e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.35e-05	9.08e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.34e-05	9.06e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.34e-05	9.04e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.33e-05	8.94e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.33e-05	8.94e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.32e-05	8.9e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.32e-05	8.88e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	1.31e-05	8.82e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.3e-05	8.76e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.3e-05	8.73e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.28e-05	8.64e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.28e-05	8.64e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.28e-05	8.63e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.28e-05	8.62e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.26e-05	8.49e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.24e-05	8.34e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.24e-05	8.32e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.23e-05	8.32e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.23e-05	8.28e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.22e-05	8.24e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.22e-05	8.2e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.21e-05	8.18e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.21e-05	8.16e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.21e-05	8.15e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.2e-05	8.11e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.2e-05	8.1e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.2e-05	8.06e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.19e-05	8.02e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.19e-05	7.99e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.18e-05	7.93e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.17e-05	7.92e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.17e-05	7.88e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.17e-05	7.86e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.17e-05	7.86e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.16e-05	7.8e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.15e-05	7.76e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.15e-05	7.76e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.15e-05	7.73e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.14e-05	7.66e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.14e-05	7.65e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.12e-05	7.54e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.12e-05	7.53e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.11e-05	7.5e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.11e-05	7.49e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.09e-05	7.38e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.08e-05	7.31e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.08e-05	7.29e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.07e-05	7.22e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.07e-05	7.19e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.06e-05	7.17e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.06e-05	7.12e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.06e-05	7.12e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.05e-05	7.08e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.04e-05	7e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.04e-05	6.98e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.04e-05	6.98e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.03e-05	6.95e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.02e-05	6.85e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.01e-05	6.84e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1e-05	6.76e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.98e-06	6.73e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.95e-06	6.71e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.81e-06	6.61e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.79e-06	6.6e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.71e-06	6.54e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.71e-06	6.54e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.65e-06	6.51e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.55e-06	6.44e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.54e-06	6.43e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.35e-06	6.3e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.35e-06	6.3e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.3e-06	6.27e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.23e-06	6.22e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.21e-06	6.21e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.16e-06	6.17e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.11e-06	6.14e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.03e-06	6.08e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.98e-06	6.05e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.96e-06	6.04e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.91e-06	6.01e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.81e-06	5.94e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.81e-06	5.94e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.78e-06	5.92e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.77e-06	5.91e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.74e-06	5.89e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.7e-06	5.86e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.7e-06	5.86e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.67e-06	5.84e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.6e-06	5.79e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.56e-06	5.77e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.08e-06	5.45e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.07e-06	5.44e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.96e-06	5.37e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.96e-06	5.37e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.95e-06	5.36e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.93e-06	5.34e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.88e-06	5.31e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.85e-06	5.29e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.8e-06	5.26e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.58e-06	5.11e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.54e-06	5.08e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.33e-06	4.94e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.24e-06	4.88e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.22e-06	4.87e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.19e-06	4.84e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.1e-06	4.78e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.94e-06	4.68e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.9e-06	4.65e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.71e-06	4.53e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.65e-06	4.49e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.61e-06	4.45e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.55e-06	4.41e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.09e-06	4.11e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.99e-06	4.04e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.96e-06	4.02e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.45e-06	3.68e-05	CbGpPWpGaD
